JPRN-jRCT2080224805已完成3 期
A Phase 3, open-label study to evaluate NS-32 in subjects with iron deficiency anemia associated with postpartum hemorrhage
ippon Shinyaku Co., Ltd.0 个研究点目标入组 21 人开始时间: 2019年7月29日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 21
研究概览
简要总结
There was a significant difference in the maximum change in hemoglobin concentration from baseline for the primary endpoint. All TEAEs were mild except for the moderate jaundice neonatal reported in 1 neonate and no serious related SAEs were reported.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 39age old（—）
- 性别
- Female
入选标准
- •Patients diagnosed with IDA associated with postpartum heamorrhage
排除标准
- •Patients with anemia due to causes other than iron deficiency
研究者
相似试验
已完成
3 期
Open Label Study (Phase III) of NS-32 in Patients with Iron Deficiency Anemia Associated with Gastrointestinal DiseasesIron Deficiency AnemiaJPRN-jRCT2080224507ippon Shinyaku Co., Ltd.40
已完成
3 期
Confirmatory Open-label Saccharated Iron Oxide-controlled Study of NS-32 in Patients with Iron Deficiency Anemia Associated with Menorrhagia (Phase III)Iron Deficiency AnemiaJPRN-jRCT2080224508ippon Shinyaku Co., Ltd.357
终止
2 期
Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With AnemiaAnaemiaAnemiaNCT02075463GlaxoSmithKline15
已完成
2 期
A Study of Four Dosing Regimens of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease. Protocol Addendum: Extension Study of Maintenance Therapy of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease.Chronic Kidney DiseaseAnemiaNCT00212875Johnson & Johnson Pharmaceutical Research & Development, L.L.C.267
已完成
不适用
The changes of noninvasive hemoglobin and perfusion index of Pulse CO-Oximetry during induction of general anesthesiaKCT0001163Chung-Ang Univerisity Hospital26